🧫
Leukocyte gene expression analysis in COVID-19 patients
active
experiment
Created: 2026-04-10T14:42:34
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-c98631a3-a95e-4621-a68f-9cf145b22b97
🧫 Experiment Protocol
ExploratoryCOVID-19P2RX1, P2RX4, P2RX5, P2RX7, P2RY1, P2RY12, PANX1, ADORA2B, NLRP3, F3, ENTPD1, CD38human leukocytes from COVID-19 patientsproposed
Analysis of gene expression profiles in leukocytes from COVID-19 patients compared to healthy controls using microarray data from public datasets. The study examined expression of purinergic signaling genes including P2 receptors (P2RX1, P2RX4, P2RX5, P2RX7, P2RY1, P2RY12), pannexin 1 (PANX1), adenosine receptor A2B (ADORA2B), NLRP3 inflammasome, tissue factor (F3), and ectoenzymes (ENTPD1, CD38). Gene expression data was obtained from Gene Expression Omnibus (GEO) databases and analyzed using bioinformatics approaches to identify upregulated purinergic signaling components.
PRIMARY OUTCOME
differential gene expression of purinergic signaling components
EXPECTED OUTCOMES
Upregulation of purinergic receptor genes and ectoenzymes in COVID-19 patients compared to controls
SUCCESS CRITERIA
Significant upregulation of target genes in COVID-19 patients
PROTOCOL
Raw genomics data from COVID-19 patient samples obtained by microarray from GEO databases, analyzed using bioinformatics and statistical methods
LINKED HYPOTHESES
h-9adb5c9e· Gap Junction Hemichannel Modulation for Controlled Mitochondrial Exchangeh-f10d82a7· NLRP3/Mitophagy Coupling Modulationh-fcbc4065· NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplificationh-5daecb6e· Microglial Purinergic Reprogrammingh-f99ce4ca· Purinergic P2Y12 Inverse Agonist Therapy
Source: PMID 35091759 ↗
🧫 Experiment Extras
PATHWAY
purinergic signaling pathway, adenosinergic pathway, inflammasome pathway
MARKET PRICE
$0.50
STATUS
proposed
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.